Particle.news
Download on the App Store

Zverev Injects Insulin During Wimbledon Final While Managing Type 1 Diabetes

The public injection highlights how elite players manage chronic disease and raises scrutiny of a June glucose‑sensor malfunction now being investigated

Overview

  • Alexander Zverev injected a dose of insulin on court during the men’s Wimbledon final on Sunday to manage his Type 1 diabetes.
  • Wimbledon officials say Zverev has a medical exemption that lets him use a phone on court to read a continuous glucose monitor instead of doing finger‑prick tests.
  • At a Halle warmup in June a sensor gave a falsely high reading, which led Zverev to inject too much insulin and then consume about 350 grams of sugar during the match to correct his levels.
  • Zverev told reporters he has used glucose sensors for more than a decade and that the device maker is investigating the Halle malfunction to determine what went wrong.
  • Zverev has made his condition public since 2022 and launched a foundation to help children with diabetes, and his visibility may prompt closer review of sensor safety and tournament medical rules.